Proton beam therapy for medulloblastoma - Author's reply

Affiliations

¹ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: TYOCK@mgh.harvard.edu.
² Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
³ Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
⁴ Department of Pediatric Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁵ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
⁶ Department of Pediatric Endocrinology, Massachusetts General Hospital, Boston, MA, USA.
⁷ Department of Pediatric Neurology, Massachusetts General Hospital, Boston, MA, USA.
⁸ Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
⁹ Department of Child Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
¹⁰ Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.

Comment

Torunn I Yock et al. Lancet Oncol. 2016 May.

. 2016 May;17(5):e174-5.

doi: 10.1016/S1470-2045(16)30061-4. Epub 2016 Apr 27.

¹ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: TYOCK@mgh.harvard.edu.
² Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
³ Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
⁴ Department of Pediatric Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁵ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
⁶ Department of Pediatric Endocrinology, Massachusetts General Hospital, Boston, MA, USA.
⁷ Department of Pediatric Neurology, Massachusetts General Hospital, Boston, MA, USA.
⁸ Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
⁹ Department of Child Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
¹⁰ Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

Comment on

Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Yock TI, et al. Lancet Oncol. 2016 Mar;17(3):287-298. doi: 10.1016/S1470-2045(15)00167-9. Epub 2016 Jan 30. Lancet Oncol. 2016. PMID: 26830377 Clinical Trial.
Proton beam therapy for medulloblastoma.
Jones B. Jones B. Lancet Oncol. 2016 May;17(5):e173. doi: 10.1016/S1470-2045(16)00084-X. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301034 No abstract available.
Proton beam therapy for medulloblastoma.
Ramaswamy V, Bouffet E. Ramaswamy V, et al. Lancet Oncol. 2016 May;17(5):e173-4. doi: 10.1016/S1470-2045(16)00156-X. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301035 No abstract available.
Proton beam therapy for medulloblastoma.
English M, Grundy RG, Peet A, Lowis S, Walker D. English M, et al. Lancet Oncol. 2016 May;17(5):e174. doi: 10.1016/S1470-2045(16)00102-9. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301037 No abstract available.